Scientists revisit biochemical basis for depression

February 12, 2013, Yale University

Symptoms of depression and anxiety can be induced in mice by increasing levels of acetylcholine, suggesting that depression may have different biochemical roots than previously believed, Yale School of Medicine researchers report the week of Feb. 11 in the journal Proceedings of the National Academy of Sciences.

A quarter of a century ago, the introduction of Prozac changed how depression was treated. The brain that respond to the and is called a SSRI, or serotonin reuptake inhibitor. Today, the most commonly prescribed antidepressants are SSRIs.

However, the new study suggests depression could arise from disruption of a different neurotransmitter system.

"We have actually seen depression-like behavior in mice when there is a breakdown in a acetylcholine regulation," said Marina Picciotto, the Charles B. G. Murphy Professor of Psychiatry and professor of neurobiology and of pharmacology and senior author of the paper. "We have also seen altered acetylcholine levels in the brain of people with depression, which shows that this is a good model for the human illness."

The team also found that they could reduce those same symptoms in mice by introduction of an SSRI. Picciotto said the findings suggest that it is possible that depression is not caused by disruption of serotonin signaling at all.

"Serotonin may be treating the problem, but acetylcholine disruption may be a primary cause," said Picciotto. "If we can treat the root cause, perhaps we can get a better response from the patient."

Explore further: Are older antidepressants better for depression in Parkinson's disease?

Related Stories

Are older antidepressants better for depression in Parkinson's disease?

December 17, 2008
A new study shows that antidepressant drugs which only affect serotonin, often used as first choice treatments, may not be best for depression in people with Parkinson's disease. The new research is published in the December ...

New target for antidepressants revealed in animal study

May 31, 2010
University of Michigan scientists have provided the most detailed picture yet of a key receptor in the brain that influences the effectiveness of serotonin-related antidepressants, such as Prozac.

Research suggests mechanism for acne drug's link to depression

November 12, 2007
New research has found that a drug used to treat severe forms of acne reduces the availability of the chemical serotonin, low levels of which have been linked to aggression and clinical depression.

Studies seek better understanding and treatment of depression

August 14, 2012
Connecting the dots between two molecules whose levels are decreased in depression and increased by current antidepressants could yield new therapies, researchers say.

New model for probing antidepressant actions

February 18, 2011
medicines such as Prozac, Lexapro and Paxil – work by blocking the serotonin transporter, a brain protein that normally clears away the mood-regulating chemical serotonin. Or so the current thinking goes.

Sex differences in the brain's serotonin system

February 13, 2008
A new thesis from he Swedish medical university Karolinska Institutet shows that the brain’s serotonin system differs between men and women. The scientists who conducted the study think that they have found one of the reasons ...

Recommended for you

Breakthrough could impact cancer, ageing and heart disease

July 20, 2018
A team of Sydney scientists has made a groundbreaking discovery in telomere biology, with implications for conditions ranging from cancer to ageing and heart disease. The research project was led by Dr. Tony Cesare, Head ...

Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model

July 20, 2018
Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.